0001209191-20-037360.txt : 20200617
0001209191-20-037360.hdr.sgml : 20200617
20200617173508
ACCESSION NUMBER: 0001209191-20-037360
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20200615
FILED AS OF DATE: 20200617
DATE AS OF CHANGE: 20200617
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Robinson William Hewitt
CENTRAL INDEX KEY: 0001773948
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38935
FILM NUMBER: 20970656
MAIL ADDRESS:
STREET 1: 500 SAGINAW DRIVE
CITY: REDWOOD CITY
STATE: CA
ZIP: 94063
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: Atreca, Inc.
CENTRAL INDEX KEY: 0001532346
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 273723255
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 450 EAST JAMIE COURT
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-595-2595
MAIL ADDRESS:
STREET 1: 450 EAST JAMIE COURT
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-06-15
0
0001532346
Atreca, Inc.
BCEL
0001773948
Robinson William Hewitt
C/O ATRECA, INC., 450 EAST JAMIE COURT
SOUTH SAN FRANCISCO
CA
94080
1
0
0
0
Class A Common Stock
2020-06-15
4
S
0
1005
17.4812
D
428856
D
Class A Common Stock
2020-06-15
4
S
0
1801
18.4307
D
427055
D
Class A Common Stock
2020-06-15
4
S
0
2194
19.1274
D
424861
D
The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 16, 2020.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.96 to $17.94, inclusive. The reporting person undertakes to provide to Atreca, Inc., any security holder of Atreca, Inc., or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $17.97 to $18.78, inclusive. The reporting person undertakes to provide to Atreca, Inc., any security holder of Atreca, Inc., or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $18.98 to $19.35, inclusive. The reporting person undertakes to provide to Atreca, Inc., any security holder of Atreca, Inc., or the staff of the Securities and Exchange Commission, upon request,full information regarding the number of shares sold at each separate price within the ranges set forth in this Form 4.
/s/ Herbert Cross, attorney-in-fact
2020-06-16